Literature DB >> 26879218

Inhibitory Effect of 8-Halogenated 7-Deaza-2'-deoxyguanosine Triphosphates on Human 8-Oxo-2'-deoxyguanosine Triphosphatase, hMTH1, Activities.

Yizhen Yin1, Shigeki Sasaki1, Yosuke Taniguchi2.   

Abstract

hMTH1 (8-oxo-2'-deoxyguanine triphosphatase) hydrolyzes oxidized nucleoside triphosphates; its presence is non-essential for survival of normal cells but is required for survival of cancer cells. In this study, 8-halogenated-7-deaza-2'-deoxyguanosine triphosphate (8-halogenated-7-deazadGTP) derivatives were synthesized. Interestingly, these triphosphates were poor substrates for hMTH1, but exhibited strong competitive inhibition against hMTH1 at nanomolar levels. This inhibitory effect is attributed to slower rate of hydrolysis, possibly arising from enzyme structural changes, specifically different stacking interactions with 8-halogenated-7-deazadGTP. This is the first example of using nucleotide derivatives to inhibit hMTH1, thus demonstrating their potential as antitumor agents.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  cancer; hMTH1; halogenated deazadeoxyguanosine triphosphate; inhibitors; oxo-dGTP

Mesh:

Substances:

Year:  2016        PMID: 26879218     DOI: 10.1002/cbic.201500589

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  3 in total

1.  Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense.

Authors:  Ya Gao; Lihan Zhu; Jing Guo; Ting Yuan; Liqing Wang; Hua Li; Lixia Chen
Journal:  Oncotarget       Date:  2017-09-30

2.  Development of MTH1-Binding Nucleotide Analogs Based on 7,8-Dihalogenated 7-Deaza-dG Derivatives.

Authors:  Hui Shi; Ren Ishikawa; Choon Han Heh; Shigeki Sasaki; Yosuke Taniguchi
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

Review 3.  Targeting human MutT homolog 1 (MTH1) for cancer eradication: current progress and perspectives.

Authors:  Yizhen Yin; Fener Chen
Journal:  Acta Pharm Sin B       Date:  2020-03-30       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.